Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2008
11/06/2008WO2008134553A1 Methods of using bicyclic compounds in treating sodium channel-mediated diseases
11/06/2008WO2008133288A1 Tricyclic aryl compounds
11/06/2008WO2008133173A1 Processed product of fenugreek seed, and method for production thereof
11/06/2008WO2008133157A1 Body-temperature lowering depressant
11/06/2008WO2008133141A1 Osmotin recombinant protein, method for production of the same, and use of the same
11/06/2008WO2008133132A1 Method for improvement in activities of reactive oxygen species-scavenging enzymes
11/06/2008WO2008132846A1 Tricyclic heteroaryl compound
11/06/2008WO2008132162A1 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments
11/06/2008WO2008131912A1 Novel use of cocoa extract
11/06/2008WO2008131910A1 Use of cocoa extract
11/06/2008WO2008104975A3 Combination therapy, composition and methods for the treatment of cardiovascular disorders
11/06/2008WO2008089307A3 Delta 5 desaturase inhibitors for the treatment of pain, inflammation and cancer
11/06/2008WO2008087367A3 Substituted (phenylthiazolyl)-phenyl-propan-1-one and (phenyloxazodyl)-phenyl-propan-1-one derivatives, preparations and uses of same
11/06/2008WO2008017925A3 Pharmacodynamic hybrids endowed of hypoglycemic and no-donor activities obtained combining hydroxylated derivatives of glibenclamide and nitrooxy-substituted carboxylic acids
11/06/2008WO2007136819A3 Use of peptides containing a cholesterol interaction sequence for treating hypercholesterolemia, viral infection, obesity and diabetes
11/06/2008US20080275258 antilipemic agents for regulation or prevention of obesity; food and tea drink; reacting a flavan-3-ol with formaldehyde; used in smaller amounts, plant extracts; enzyme inhibitor as hypotensive agents, antidiabetic agent, aging resistance, anticarcinogenic agent
11/06/2008US20080275124 Powder of amino acids and method for producing the same
11/06/2008US20080275102 And 3-oximidoindole derivatives; cannabinoid receptor antagonists; cardiovascular, gastrointestinal, autoimmune, and neurodegenerative disorders; obesity, infections; antidiabetic and antiallergen agents; acylation, oximination
11/06/2008US20080275098 Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
11/06/2008US20080275093 Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]-, (4-methyl-5-oxido-1,2,5-oxadiazol-3-yl)methyl ester; oxatriazole-5-ones and/or oxatriazole-5-imines etc. are linked to the diuretic compounds through one or more sites such as O, N, S; cardiovascular, diabetes, oxidatives stress
11/06/2008US20080275088 Use of Collismycin and Derivatives Thereof as Oxidative Stress Inhibitors
11/06/2008US20080275087 Biphenylcarboxamides useful as lipid lowering agents
11/06/2008US20080275086 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes
11/06/2008US20080275072 Weekly administration of dipeptidyl peptidase inhibitors
11/06/2008US20080275069 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders
11/06/2008US20080275064 N-(2-Furan-2-yl-6-pyrazol-1-yl-pyrimidin-4-yl)-2-piperidin-1-yl-acetamide; antiischemic agents, antidiabetics; autoimmune diseases, Asthma, Obesity, Huntington's Disease, Dystonia, Dyskinesias, Parkinson's Disease, Inflammatory Bowl Disease
11/06/2008US20080275052 Especially p38 MAP kinase alpha and beta; 2,4-difluorophenyl(3-(2-(trifluoromethyl)phenyl)-5,6-dihydroimidazo[1,5-a]pyrazin-7(8H)-yl)methanone
11/06/2008US20080275046 1-(3-{4-[4-(piperidin-1-ylmethyl)-1,3-oxazol-2-yl]phenoxy}propyl)piperidine; 4,4-difluoro-1-[(4-methyl-2-{4-[3-(2-methylpyrrolidin-1-yl)propoxy]phenyl}-1,3-thiazol-5-yl)carbonyl]piperidine; histamine H3-receptor antagonists; Parkinson's and Alzheimer's diseases; sleep disorders; antiepileptics
11/06/2008US20080275043 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1
11/06/2008US20080275037 2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
11/06/2008US20080275023 N-Hydroxyamides Omege-Substituted with Tricyclic Groups as Histone Deacetylase Inhibitors, Their Preparation and Use in Pharmaceutical Formulations
11/06/2008US20080275013 Mixture of androgen, macrocyclic ketone enhancer and thickener; glandular disorders
11/06/2008US20080275012 Mixture of androgen, such as testosterone, macrocyclic ketone enhancer and thickener; therapy for glandular disorders
11/06/2008US20080275007 Charged phospholipid compositions and methods for their use
11/06/2008US20080275005 Mitochondrially targeted antioxidants
11/06/2008US20080274987 Novel alpha glucosidase activator, pulicarside 1
11/06/2008US20080274947 Antilipemic agents; metabolic disorders; insulin resistance; antidiabetic agents
11/06/2008US20080274945 Infant Nutrition With Protease Inhibitor
11/06/2008US20080274216 Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus
11/06/2008US20080274210 Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Method of Making Same
11/06/2008US20080274203 Having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents; antiinflammation, antioxidant effects, improving insulin resistance and blood lipid profile
11/06/2008US20080274193 Retinoic Acid-Containing Antidiabetic Agent
11/06/2008US20080274180 Low cost, simple production; tablets; increased stomach retention time; contains gas generator, release retardant, disintegrant, hydrophilic stabilizers and release modifier; unique flexibility and rigidity properties preventing expulsion through pyloric sphincter
11/06/2008US20080274143 Chloroplasts Engineering to Express Pharmaceutical Proteins
11/06/2008US20080274119 Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration
11/06/2008US20080274118 CD40 specific immunoglobulin for prevention and treatment of arthritic, cardiovascular, allergic, neurodegenerative and/or blood disorders
11/06/2008US20080274090 Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
11/06/2008US20080274045 Imaging, diagnosis and treatment of disease
11/06/2008DE10231104B4 Verwendung von mikronisiertem Calciumsulfat-Dihydrat zur Verringerung des Auftretens von Hypocalcaemien bei Milchkühen Use of micronized calcium sulfate dihydrate for reducing the occurrence of Hypocalcaemien in dairy cows
11/06/2008DE102007021403A1 Whole-egg preparation manufacturing for use in pharmaceutical formulation for medicine for treating lipoproteinaemia and controlled delivering of fennel oil ingredient to patient's transport system, involves mixing whole-egg with fennel oil
11/06/2008DE102007020492A1 Substituierte Sulfonamid-Derivate Substituted sulfonamide derivatives
11/06/2008CA2685529A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/06/2008CA2685524A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/05/2008EP1988395A1 Methods for evaluating tissue morphogenesis and morphogenic activity
11/05/2008EP1988102A1 Growth factor homolog ZVEGF3
11/05/2008EP1988100A1 Derivatives of glucagon-like peptide-2 and their therapeutic use
11/05/2008EP1988091A1 Tricyclic compounds
11/05/2008EP1987837A1 Pharmaceutical composition for increasing insulin secretion from pancreatic ß-cells
11/05/2008EP1987831A1 Compounds effecting glucokinase
11/05/2008EP1987039A2 Melanin concentrating hormone receptor-1 antagonists
11/05/2008EP1987020A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/05/2008EP1987013A1 Bicyclic sphingosine 1-phosphate analogs
11/05/2008EP1986679A2 A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
11/05/2008EP1986678A1 Dissolution aids for oral peptide delivery comprising a biguanide
11/05/2008EP1986670A2 Intestinal alpha-glucosidase inhibitors and a process for the isolation and use thereof
11/05/2008EP1986663A2 Adenosine monophosphate for inducing torpor in a subject
11/05/2008EP1986652A2 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/05/2008EP1986646A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
11/05/2008EP1986645A1 Glucokinase activators
11/05/2008EP1986638A2 Cb1 antagonists and inverse agonists
11/05/2008EP1986636A2 Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
11/05/2008EP1986621A1 Use of resveratrol and derivatives thereof for promoting the wellness state in mammals
11/05/2008EP1986566A1 Accelerating agent of calcium absorption
11/05/2008EP1858901B1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/05/2008EP1781659B1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof
11/05/2008EP1309544B1 Compounds acting as melanocortin receptor ligands
11/05/2008EP1216247B1 Imidazoimidazoles and triazoles as anti-inflammatory agents
11/05/2008EP1053227B1 Ppar-gamma modulators
11/05/2008EP1003532B2 Lactobacilli to increase absorption of minerals by intestinal cells
11/05/2008EP0912601B2 Suppression of immune response via inhibition of cathepsin s
11/05/2008CN101300346A Novel biological substance nesfatin and its related substances and uses thereof
11/05/2008CN101300244A Novel cercosporamide derivative
11/05/2008CN101300010A Pharmaceutical preparation having excellent photostability
11/05/2008CN101300005A N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/05/2008CN101299934A Nutritional formulation for promoting catch-up growth
11/05/2008CN101298440A Pharmaceutical salts of reboxetine
11/05/2008CN101298433A 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
11/05/2008CN101297990A Regimen using padauk and health-preserving pillow
11/05/2008CN101297963A Pharmaceutical composition of proinsulin C peptide
11/05/2008CN101297957A Non-covalent complex formed by glutathion and vitamin B group and uses thereof
11/05/2008CN101297949A Chinese medicine for preventing and treating hyperlipemia and preparation thereof
11/05/2008CN101297936A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297935A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297934A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297933A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297932A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297931A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297930A Pharmaceutical combination for preventing birth-defect and improving memory
1 ... 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 ... 1298